Exits

Name Description Event Datesort icon Acquired By
Seahorse Bioscience, Inc. XF instruments are the industry standard in cellular bioenergetic measurements. Acquired 2015 <a href="http://www.agilent.com/home" target="_blank">Agilent Technologies</a>
Seres Therapeutics Developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome. IPO 2015
Red Rock Biofuels Pioneer in renewable biofuels. Acquired 2016 <a href="http://www.jouleunlimited.com/" target="_blank">Joule Unlimited</a>
Editas Medicine Leading genome editing company translating its proprietary technology into novel solutions to treat a broad range of genetically-driven diseases. IPO 2016